Hexon Modification to Improve the Activity of Oncolytic Adenovirus Vectors against Neoplastic and Stromal Cells in Pancreatic Cancer

• Tanja Lucas,

  Affiliation Department of Gene Therapy, Ulm University, Ulm, Germany

  ⨯
• Karim Benihoud,

  Affiliation Univ. Paris-Sud, Orsay Cedex, France and CNRS UMR 8203, Institut Gustave Roussy, Villejuif Cedex, France

  ⨯
• Frédéric Vigant,

  Current Address: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, United States of America

  Affiliation Univ. Paris-Sud, Orsay Cedex, France and CNRS UMR 8203, Institut Gustave Roussy, Villejuif Cedex, France

  ⨯
• Christoph Q. Andreas Schmidt,

  Affiliations Institute of Pharmacology of Natural Products & Clinical Pharmacology, Ulm University, Ulm, Germany, Tierforschungszentrum, Ulm University, Ulm, Germany

  ⨯
• Max G. Bachem †,

  † Deceased.

  Affiliation Department of Clinical Chemistry, Ulm University, Ulm, Germany

  ⨯
• Thomas Simmet,

  Affiliation Institute of Pharmacology of Natural Products & Clinical Pharmacology, Ulm University, Ulm, Germany

  ⨯
• Stefan Kochanek

  * E-mail: stefan.kochanek@uni-ulm.de

  Affiliation Department of Gene Therapy, Ulm University, Ulm, Germany

  ⨯